Fast Money's Stem Cell Stock Picks
9545 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by barrons3
DESCRIPTION:

Date updated:02-18-2009

Considering it's widely believed that President Obama will soon issue an executive order lifting the ban on federal funding for embryonic stem-cell research -- what's the trade?

symbol name last price % change open
  • +
  • GERN
    Geron Corporation
  • $5.58
  • -2.62%
  • $5.65

Geron [GERN] is the name many traders talk about as a leader in stem cell research, says Pete Najarian. However, it’s important to keep in mind that major breakthroughs are probably a way out, still.

People owning GERN also tend to own: CELGSTEMACTC.OBALXNARIAASTMCRIS

TheStreet.com Rating: D What is this?

  • +
  • CELG
    Celgene Corporati
  • $54.91
  • +0.66%
  • $54.42

In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. Personally, my favorite stock in the space is Celgene, adds Guy Adami.

People owning CELG also tend to own: ACLALXNBMRNCVHCVSESRXGENZ

TheStreet.com Rating: B- What is this?

  • +
  • GENZ
    Genzyme Corporati
  • $50.05
  • +0.85%
  • $49.33

In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. - Pete Najarian

People owning GENZ also tend to own: LRCXWRLDAMGNDNAAMZNBLUDHPQ

TheStreet.com Rating: C+ What is this?

  • +
  • TEVA
    Teva Pharmaceutic
  • $52.72
  • -0.60%
  • $52.67

In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. - Pete Najarian

People owning TEVA also tend to own: ACEBACBSXCSCODISFGES

TheStreet.com Rating: A What is this?

  • +
  • XBI
    Spdr S&p Biotech
  • $50.17
  • -0.10%
  • $50.00

Or if you don’t want to play stock picker, you can get broad exposure with the SPDR S&P Biotech ETF[XBI]. - Pete Najarian

People owning XBI also tend to own: IGWKBEKIEVAWVCRVDEVGT

TheStreet.com Rating: No Rating What is this?

  • +
  • IBB
    Ishares Trust
  • $77.61
  • -0.32%
  • $77.79

Or you can play the iShares NASDAQ Biotechnology Index ETF [IBB], adds Karen Finerman.

People owning IBB also tend to own: ACASAINVALDDBVMGUMICMSD

TheStreet.com Rating: No Rating What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 23, 2009 As well as broad-based indexes have performed in the last few months, Stockpickr's weekly Rocket Stocks list has managed to d...

11.23.09 | 10:34 AM
Cramer's Take on Headline Stocks...

Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...

11.20.09 | 11:48 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...

11.20.09 | 08:09 AM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...

11.19.09 | 11:13 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
48 years old, IN debt, college w...
11.21.09 | 07:51 AM From author schmls
more forums
Q. In updating the professional por...
11.23.09 | 16:46 PM Asked by Stockpickr Staff #2

A. golds gonna have a blow off top. when it
goes parabolic you'll know its time to
leave.

today 's lists
Rising on Unusual Volume

Here are some stocks that moved up on unusual volume on Nov. 23, 2009. more

Biggest % Losers

Here is the stock list of some of the largest % losers from Nov. 23, 2009. more

Analyst Upgrades

Analyst Upgrades or Estimate Increases for Nov. 23, 2009. Read more here. more